effect overlay
activetrials
Brain Tumour/Neurosurgery

A clinical and molecular age-stratafied analysis of low grade glimoa (LGG) and high grade glioma (HGG) to identify tailored therapies
 

HREC: 2020.268
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Verena Schadewaldt
Funding: Non-Commercial
Brain Tumour/Neurosurgery

Responding to need: technology-enhanced brain cancer survivorship – Phase 1
 

HREC: 2021.212
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Verena Schadewaldt
Funding: Non-Commercial
Brain Tumour/Neurosurgery

A Phase 0/2 Study of AB-218 in Patients with IDH1 Mutated Low Grade Glioma
 

HREC: 2022.003
Principal Investigator: Prof Kate Drummond
Coordinator contact:
Funding: Non-Commercial

An adaptive, multi-domain platform of comprehensive translational and feasibility research to study the biology of brain and other central nervous system (CNS) cancers
 

HREC: 2022.220
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Jordan Jones
Funding: Non-Commercial
Brain Tumour/Neurosurgery

Responding to need: technology-enhanced brain cancer survivorship – Phase 2
 

HREC: 2022.264
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Verena Schadewaldt
Funding: Non-Commercial